• 

  In These 10 U.S. Counties, 1 in 6 People Over 65 Have Alzheimer’s Disease
• 

  A Peek Into the Future: Gene Therapy for Alzheimer’s
• 

  Phil’s Journal: Before AAIC In Amsterdam, Leading Alzheimer’s Advocates Weigh In
• 

  Phil’s Journal: What Is ‘Quality of Life?’ A Sad Farewell and a Tough Deciscion
• 

  The Next Anti-Amyloid in the Alzheimer’s Pipeline: Donanemab
• 

  Q&A: The Future of Gene Therapy For Alzheimer’s Disease
• 

  Op-Ed: Evidence Shows Germs May Cause Alzheimer’s—It’s Time for Researchers and Doctors to Act on It
• 

  Your AAIC 2023 Guide: Healthy Options to Eat, Drink, Explore in Amsterdam
• 

  To Protect Brain Cells, Feed Gut Bacteria What They’re Hungry For
• 

  Laurie Scherrer on Early Signs, Current Symptoms, and Living Well With Early-Onset Alzheimer’s, FTD
• 

  A Look at Rapid-Onset Dementia: My Dad’s Sudden Dementia
• 

  Are Daily Multivitamins Good for Memory?
• 

  What Do YOU Know About the New Generation of Alzheimer’s Drugs?
• 

  Our Readers Sent Legal Questions About Dementia. We Asked a Lawyer
• 

  ‘How I First Knew Something Was Wrong:’ An Oral History of Early Dementia

Previous434445Next